Magnetic Resonance Imaging Substudy in a Phase 2b Dose-Ranging Study of Baricitinib, an Oral Janus Kinase 1/Janus Kinase 2 Inhibitor, in Combination with Traditional Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis.

Authors
Publication date
1 January 2012
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    ORA - Oxford University Research Archive

    redirect
    oaioai:ora.ox.ac.uk:uuid:9e698af7...
    Last time updated on 13/04/2022
    Supporting member

    Oxford University Research Archive

    redirect
    oaioai:ora.ox.ac.uk:uuid:9e698af7...
    Last time updated on 30/09/2015